DNM2 and schizophrenia: Postmortem brain studies of schizophrenia patients revealed differences in neuron density, size, and arrangement, abnormalities in synapse-related proteins, alterations in monoaminergic and glutamatergic innervation, and receptor distribution and abnormalities in the expression of cytoskeletal proteins [55].